Japan's Stem Cell Breakthrough Restores Vision for Blind Patients
A groundbreaking stem cell treatment has restored vision in three out of four participants by repairing damaged corneas affected by limbal stem-cell deficiency (LSCD). The treatment, developed by Osaka University researchers, uses induced pluripotent stem cells to create corneal epithelial cell sheets for transplantation. Despite one participant experiencing a reversal, the results are promising, with no severe side effects observed over two years. Clinical trials are planned to further assess the treatment's efficacy.
